METAMARK GENETICS
Metamark Genetics, Inc is a life science company dedicated to the development of prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients, improved outcomes, and reduced healthcare costs. Metamark was founded in November, 2007 to transform cancer diagnosis and treatment by developing pioneering diagnostic products based on its Prognosis Determinantsâ„¢ Platform. Prognosis Determinantsâ„¢ are functionally validated genetic elements... at the core of cancer progression across many major cancer types. Based on pioneering research in melanoma by Dr. Lynda Chin at the Dana-Farber Cancer Institute and Harvard Medical School, the Prognosis Determinantsâ„¢ were first discovered as functionally active drivers of metastasis that confer poor outcome. Prognosis Determinantsâ„¢ have been shown to be relevant to a broad spectrum of different tumors and can stratify patients according to their overall and metastasis-free survival.
METAMARK GENETICS
Industry:
Biotechnology Genetics Health Care Health Diagnostics Medical Personal Health
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.metamarkgenetics.com
Total Employee:
51+
Status:
Active
Contact:
617-583-1400
Email Addresses:
[email protected]
Total Funding:
46.76 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail JsDelivr ASP.NET IIS IIS 10 Lorem Ipsum Google DNS
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
CollabRx
CollabRx uses information technology to provide personalized cancer treatment planning services to cancer patients.
Foundation Medicine
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Genes2me (P) Limited
Personalised Diagnostics: Mother & Child, D2C Genetic profiling, Oncology. IVD Manufacturing & POC RTPCR Molecular device solutions.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Metabolistics
Metabolistics uses urine based lab tests for early breast and ovarian cancer detection.
MNG Laboratories
MNG is your source for Neurogenetic Answers with a reputation for going beyond the expected to make a difference for patient care.
Rosetta Genomics
Rosetta Genomics discovers, develops and commercializes diagnostic tests for personalized medicine.
Ruby Consulting Group
Marketing, Commercialization and Medical Diligence Services for Genetics, Genomics and Health-tech Companies
Current Advisors List
Current Employees Featured
Founder
Investors List
Perseus
Perseus investment in Series B - Metamark Genetics
Official Site Inspections
http://www.metamarkgenetics.com Semrush global rank: 10.05 M Semrush visits lastest month: 57
- Host name: 146.88.104.161
- IP address: 146.88.104.161
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
